473 related articles for article (PubMed ID: 33677950)
1. Pulmonary arterial hypertension: guidelines and unmet clinical needs.
Giuggioli D; Bruni C; Cacciapaglia F; Dardi F; De Cata A; Del Papa N; Iannone F; Lunardi C; Maglione W; Molinaro F; Palazzini M; Spinella A; Tinazzi E; Matucci Cerinic M
Reumatismo; 2021 Jan; 72(4):228-246. PubMed ID: 33677950
[TBL] [Abstract][Full Text] [Related]
2. Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
Distler O; Bonderman D; Coghlan JG; Denton CP; Grünig E; Khanna D; McLaughlin VV; Müller-Ladner U; Pope JE; Vonk MC; Di Scala L; Lemarie JC; Perchenet L; Hachulla É
Arthritis Rheumatol; 2024 May; 76(5):777-782. PubMed ID: 38146100
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
[TBL] [Abstract][Full Text] [Related]
4. The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines.
Li Y; Qian J; Dong X; Zhao J; Wang Q; Wang Y; Zeng X; Tian Z; Li M
Arthritis Res Ther; 2024 May; 26(1):109. PubMed ID: 38802957
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
[TBL] [Abstract][Full Text] [Related]
6. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
[TBL] [Abstract][Full Text] [Related]
7. How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
Sarı A; Şener YZ; Armağan B; Kılıç L; Kaya EB; Hekimsoy V; Karadağ Ö; Apras Bilgen Ş; Kiraz S; Ertenli I; Tokgozoğlu L; Akdoğan A
Anatol J Cardiol; 2021 Jan; 25(1):30-35. PubMed ID: 33382047
[TBL] [Abstract][Full Text] [Related]
8. Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality.
Puigrenier S; Giovannelli J; Lamblin N; De Groote P; Fertin M; Bervar JF; Lamer A; Edmé JL; Balquet MH; Sobanski V; Launay D; Hachulla É; Sanges S
Respir Res; 2022 Oct; 23(1):284. PubMed ID: 36243869
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
10. High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center.
Guillén-Del Castillo A; Callejas-Moraga EL; García G; Rodríguez-Palomares JF; Román A; Berastegui C; López-Meseguer M; Domingo E; Fonollosa-Plá V; Simeón-Aznar CP
Arthritis Res Ther; 2017 Jun; 19(1):135. PubMed ID: 28615037
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary arterial hypertension.
Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R
Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240
[TBL] [Abstract][Full Text] [Related]
14. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
Karia N; Howard L; Johnson M; Kiely DG; Lordan J; McCabe C; Pepke-Zaba J; Ong R; Preiss M; Knight D; Muthurangu V; Coghlan JG
Eur Heart J; 2023 Nov; 44(44):4678-4691. PubMed ID: 37619574
[TBL] [Abstract][Full Text] [Related]
15. Definitions and diagnosis of pulmonary hypertension.
Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
[TBL] [Abstract][Full Text] [Related]
16. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
[TBL] [Abstract][Full Text] [Related]
17. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
[TBL] [Abstract][Full Text] [Related]
18. [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].
Hachulla E; Launay D; Le Pavec J; Mouthon L; Guillevin L; de Groote P
Presse Med; 2011 Apr; 40 Suppl 1():1S46-53. PubMed ID: 21536180
[TBL] [Abstract][Full Text] [Related]
19. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
